1. Home
  2. MATH vs GNTA Comparison

MATH vs GNTA Comparison

Compare MATH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$2.95

Market Cap

145.4M

Sector

Finance

ML Signal

N/A

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.78

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
GNTA
Founded
2015
2014
Country
Hong Kong
Italy
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.4M
39.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MATH
GNTA
Price
$2.95
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
108.0K
100.7K
Earning Date
12-05-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$44,567,257.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.37
N/A
Revenue Growth
165.86
N/A
52 Week Low
$0.99
$1.35
52 Week High
$4.17
$10.00

Technical Indicators

Market Signals
Indicator
MATH
GNTA
Relative Strength Index (RSI) 48.10 38.43
Support Level $2.84 $1.80
Resistance Level $3.12 $2.07
Average True Range (ATR) 0.19 0.22
MACD 0.02 0.03
Stochastic Oscillator 52.17 50.59

Price Performance

Historical Comparison
MATH
GNTA

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: